RIPK3 and cancer: Indeed, RIPK3 has been demonstrated to regulate the production of downstream ROS [101, 102] and could activate multiple metabolic enzymes to modulate TNF-induced ROS production [51] during the process of necroptosis, which jointly induces a considerable production of ROS, thus enabling necroptosis to kill metastatic cancer cells by incurring ROS bursts.